Ten Emerging Trends in the Epidemiology of Diabetic Retinopathy

References

• Guariguata L, Whiting DR, Hambleton I, et al. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 2014;103:137–149.
   PubMed Web of Science ®Google Scholar
• Burgess PI, MacCormick IJ, Harding SP, et al. Epidemiology of diabetic retinopathy and maculopathy in Africa: a systematic review. Diabet Med 2013;30:399–412.
   PubMed Web of Science ®Google Scholar
• Cockram CS. The epidemiology of diabetes mellitus in the Asia-Pacific region. Hong Kong Med J 2000;6:43–52.
   PubMedGoogle Scholar
• Khandekar R. Screening and public health strategies for diabetic retinopathy in the Eastern Mediterranean region. Middle East Afr J Ophthalmol 2012;19:178–184.
   PubMedGoogle Scholar
• Klein R, Klein BE. Are individuals with diabetes seeing better? A long-term epidemiological perspective. Diabetes 2010;59:1853–1860.
   PubMed Web of Science ®Google Scholar
• Lee R, Wong TY, Sabanayagam C. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis (Lond) 2015;2:17.
   PubMedGoogle Scholar
• World Health Organization. Global initiative for the elimination of avoidable blindness Action Plan 2006–2011. Vision 2020, Report 2007.
   Google Scholar
• Yau JW, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012;35:556–564.
   PubMed Web of Science ®Google Scholar
• The Diabetes Control and Complications Trial Research Group. Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial, 1995;102:647–661.
   Google Scholar
• The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977–986.
   Google Scholar
• UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837–853.
   PubMed Web of Science ®Google Scholar
• UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998;317:703–713.
   Google Scholar
• The Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. Ophthalmology 1981;88:583–600.
   Google Scholar
• Early Treatment Diabetic Retinopathy Study Research Group. Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS report no. 19. Arch Ophthalmol 1995;113:1144–1155.
   Google Scholar
• Mitchell P, Wong TY. Management paradigms for diabetic macular edema. Am J Ophthalmol 2014;157:505–513.
   PubMed Web of Science ®Google Scholar
• Shi L, Wu H, Dong J, et al. Telemedicine for detecting diabetic retinopathy: a systematic review and meta-analysis. Br J Ophthalmol 2015;99:823–831.
   PubMed Web of Science ®Google Scholar
• Kirkizlar E, Serban N, Sisson JA, et al. Evaluation of telemedicine for screening of diabetic retinopathy in the Veterans Health Administration. Ophthalmology 2013;120:2604–2610.
   PubMed Web of Science ®Google Scholar
• Jones S, Edwards RT. Diabetic retinopathy screening: a systematic review of the economic evidence. Diabet Med 2010;27:249–256.
   PubMed Web of Science ®Google Scholar
• Mansberger SL, Sheppler C, Barker G et al. Long-term comparative effectiveness of telemedicine in providing diabetic retinopathy screening examinations: a randomized clinical trial. JAMA Ophthalmol 2015;133:518–525.
   PubMed Web of Science ®Google Scholar
• Virgili G, Menchini F, Casazza G, et al. Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy. Cochrane Database Syst Rev 2015;1:CD008081.
   PubMed Web of Science ®Google Scholar
• Adhi M, Duker JS. Optical coherence tomography – current and future applications. Curr Opin Ophthalmol 2013;24:213–221.
   PubMed Web of Science ®Google Scholar
• Zimmer-Galler IE, Kimura AE, Gupta S. Diabetic retinopathy screening and the use of telemedicine. Curr Opin Ophthalmol 2015;26:167–172.
   PubMed Web of Science ®Google Scholar
• Boyer DS, Hopkins JJ, Sorof J, et al. Anti-vascular endothelial growth factor therapy for diabetic macular edema. Ther Adv Endocrinol Metab 2013;4:151–169.
   PubMedGoogle Scholar
• Agarwal A, Afridi R, Hassan M, et al. Novel therapies in development for diabetic macular edema. Curr Diab Rep 2015;15:75.
   PubMed Web of Science ®Google Scholar
• King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care 1998;21:1414–1431.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Diabetes Programme.Geneva: WHO, 2015.
   Google Scholar
• International Diabetes Federation. IDF Diabetes atlas, 7th ed. Brussels, Belgium: Author, 2015. Accessed December 20, 2015 from: http://www diabetesatlas org
   Google Scholar
• Foundation ID. IDF Diabetes atlas, 6th ed. 2014. Accessed December 22, 2015 from: https://www idf org/sites/default/files/Atlas-poster-2014_EN pdf [serial online]
   Google Scholar
• Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87:4–14.
   PubMed Web of Science ®Google Scholar
• Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047–1053.
   PubMed Web of Science ®Google Scholar
• Stovring H, Andersen M, Beck-Nielsen H, et al. Rising prevalence of diabetes: evidence from a Danish pharmaco-epidemiological database. Lancet 2003;362:537–538.
   PubMed Web of Science ®Google Scholar
• Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet 2010;376:124–136.
   PubMed Web of Science ®Google Scholar
• Nordwall M, Bojestig M, Arnqvist HJ, et al. Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of Type 1 diabetes – The Linkoping Diabetes Complications Study. Diabetologia 2004;47:1266–1272.
   PubMed Web of Science ®Google Scholar
• Hovind P, Tarnow L, Rossing K, et al. Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care 2003;26:1258–1264.
   PubMed Web of Science ®Google Scholar
• Pambianco G, Costacou T, Ellis D, et al. The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes 2006;55:1463–1469.
   PubMed Web of Science ®Google Scholar
• Cugati S, Kifley A, Mitchell P, et al. Temporal trends in the age-specific prevalence of diabetes and diabetic retinopathy in older persons: population-based survey findings. Diabetes Res Clin Pract 2006;74:301–308.
   PubMed Web of Science ®Google Scholar
• Wong TY, Mwamburi M, Klein R, et al. Rates of progression in diabetic retinopathy during different time periods: a systematic review and meta-analysis. Diabetes Care 2009;32:2307–2313.
   PubMed Web of Science ®Google Scholar
• Arun CS, Ngugi N, Lovelock L, et al. Effectiveness of screening in preventing blindness due to diabetic retinopathy. Diabet Med 2003;20:186–190.
   PubMed Web of Science ®Google Scholar
• Hu FB. Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care 2011;34:1249–1257.
   PubMed Web of Science ®Google Scholar
• Ibrahim MM, Damasceno A. Hypertension in developing countries. Lancet 2012;380:611–619.
   PubMed Web of Science ®Google Scholar
• Klein R, Knudtson MD, Lee KE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology 2008;115:1859–1868.
   PubMed Web of Science ®Google Scholar
• Reddy KS, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation 1998;97:596–601.
   PubMed Web of Science ®Google Scholar
• Zhang X, Saaddine JB, Chou CF, et al. Prevalence of diabetic retinopathy in the United States, 2005–2008. JAMA 2010;304:649–656.
   PubMed Web of Science ®Google Scholar
• Varma R, Choudhury F, Klein R, et al. Four-year incidence and progression of diabetic retinopathy and macular edema: the Los Angeles Latino Eye Study. Am J Ophthalmol 2010;149:752–761.
   PubMed Web of Science ®Google Scholar
• Minassian DC, Owens DR, Reidy A. Prevalence of diabetic macular oedema and related health and social care resource use in England. Br J Ophthalmol 2012;96:345–349.
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema. Ophthalmology 1995;102:7–16.
   Google Scholar
• Ding J, Wong TY. Current epidemiology of diabetic retinopathy and diabetic macular edema. Curr Diab Rep 2012;12:346–354.
   PubMed Web of Science ®Google Scholar
• Klein R, Knudtson MD, Lee KE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes. Ophthalmology 2009;116:497–503.
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 1998;105:1801–1815.
   Google Scholar
• Romero-Aroca P, Baget-Bernaldiz M, Fernandez-Ballart J, et al. Ten-year incidence of diabetic retinopathy and macular edema. Risk factors in a sample of people with type 1 diabetes. Diabetes Res Clin Pract 2011;94:126–132.
   PubMed Web of Science ®Google Scholar
• Martin-Merino E, Fortuny J, Rivero-Ferrer E, et al. Incidence of retinal complications in a cohort of newly diagnosed diabetic patients. PLoS One 2014;9:e100283.
   PubMed Web of Science ®Google Scholar
• Leske MC, Wu SY, Hennis A, et al. Nine-year incidence of diabetic retinopathy in the Barbados Eye Studies. Arch Ophthalmol 2006;124:250–255.
   PubMedGoogle Scholar
• Younis N, Broadbent DM, Harding SP, et al. Incidence of sight-threatening retinopathy in Type 1 diabetes in a systematic screening programme. Diabetic Med 2003;20:758–765.
   PubMed Web of Science ®Google Scholar
• Younis N, Broadbent DM, Vora JP, et al. Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study. Lancet 2003;361:195–200.
   PubMed Web of Science ®Google Scholar
• Jones CD, Greenwood RH, Misra A, et al. Incidence and progression of diabetic retinopathy during 17 years of a population-based screening program in England. Diabetes Care 2012;35:592–596.
   PubMed Web of Science ®Google Scholar
• Thomas RL, Dunstan F, Luzio SD, et al. Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis. BMJ 2012;344:e874.
   PubMed Web of Science ®Google Scholar
• Gibson DM. Diabetic retinopathy and age-related macular degeneration in the U.S. Am J Prev Med 2012;43:48–54.
   Google Scholar
• Bressler NM, Varma R, Doan QV, et al. Underuse of the health care system by persons with diabetes mellitus and diabetic macular edema in the United States. JAMA Ophthalmol 2014;132:168–173.
   PubMed Web of Science ®Google Scholar
• Funatsu H, Hori S, Shimizu E, et al. Questionnaire survey on periodic ocular examination in Japanese diabetic patients. Am J Ophthalmol 2003;136:955–957.
   PubMed Web of Science ®Google Scholar
• Huang OS, Tay WT, Ong PG, et al. Prevalence and determinants of undiagnosed diabetic retinopathy and vision-threatening retinopathy in a multiethnic Asian cohort: the Singapore Epidemiology of Eye Diseases (SEED) study. Br J Ophthalmol 2015;99:1614–1621.
   PubMed Web of Science ®Google Scholar
• Dandona R, Dandona L, John RK, et al. Awareness of eye diseases in an urban population in southern India. Bull World Health Organ 2001;79:96–102.
   PubMed Web of Science ®Google Scholar
• Thapa R, Paudyal G, Maharjan N, et al. Awareness of diabetic retinopathy among diabetic patients in Nepal. Acta Ophthalmol 2012;90:e242.
   PubMed Web of Science ®Google Scholar
• Abueleinen KG, El-Mekawey H, Saif YS, et al. Sociodemographic factors responsible for blindness in diabetic Egyptian patients. Clin Ophthalmol 2011;5:1593–1598.
   PubMedGoogle Scholar
• Wang S, Tikellis G, Wong N, et al. Lack of knowledge of glycosylated hemoglobin in patients with diabetic retinopathy. Diabetes Res Clin Pract 2008;81:e15–e17.
   Google Scholar
• Tajunisah I, Wong P, Tan L, et al. Awareness of eye complications and prevalence of retinopathy in the first visit to eye clinic among type 2 diabetic patients. Int J Ophthalmol 2011;4:519–524.
   PubMed Web of Science ®Google Scholar
• Huang OS, Tay WT, Tai ES, et al. Lack of awareness amongst community patients with diabetes and diabetic retinopathy: the Singapore Malay eye study. Ann Acad Med Singapore 2009;38:1048–1055.
   PubMed Web of Science ®Google Scholar
• Islam FM, Chakrabarti R, Islam SZ, et al. Factors associated with awareness, attitudes and practices regarding common eye diseases in the general population in a rural district in Bangladesh: The Bangladesh Population-based Diabetes and Eye Study (BPDES). PLoS One 2015;10:e0133043.
   Google Scholar
• Jin P, Peng J, Zou H, et al. The 5-year onset and regression of diabetic retinopathy in Chinese type 2 diabetes patients. PLoS One 2014;9:e113359.
   PubMed Web of Science ®Google Scholar
• Tam VH, Lam EP, Chu BC, et al. Incidence and progression of diabetic retinopathy in Hong Kong Chinese with type 2 diabetes mellitus. J Diabetes Complications 2009;23:185–193.
   PubMed Web of Science ®Google Scholar
• The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977–986.
   Google Scholar
• Diabetes Control and Complications Trial Research Group. Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Ophthalmology 1995;102:647–661.
   Google Scholar
• The Diabetes Control and Complications Trial Research Group. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 1995;44:968–983.
   Google Scholar
• The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 2000;342:381–389.
   PubMed Web of Science ®Google Scholar
• Wang PH, Lau J, Chalmers TC. Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes. Lancet 1993;341:1306–1309.
   PubMed Web of Science ®Google Scholar
• Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial. Arch Ophthalmol 1998;116:874–886.
   Google Scholar
• Egger M, Davey SG, Stettler C, et al. Risk of adverse effects of intensified treatment in insulin-dependent diabetes mellitus: a meta-analysis. Diabet Med 1997;14:919–928.
   PubMed Web of Science ®Google Scholar
• Cheng YJ, Gregg EW, Geiss LS, et al. Association of A1C and fasting plasma glucose levels with diabetic retinopathy prevalence in the U.S. population: implications for diabetes diagnostic thresholds. Diabetes Care 2009;32:2027–2032.
   PubMed Web of Science ®Google Scholar
• Chiang PP, Lamoureux EL, Cheung CY, et al. Racial differences in the prevalence of diabetes but not diabetic retinopathy in a multi-ethnic Asian population. Invest Ophthalmol Vis Sci 2011;52:7586–7592.
   PubMed Web of Science ®Google Scholar
• Dowse GK, Humphrey AR, Collins VR, et al. Prevalence and risk factors for diabetic retinopathy in the multiethnic population of Mauritius. Am J Epidemiol 1998;147:448–457.
   PubMed Web of Science ®Google Scholar
• Pradeepa R, Anjana RM, Unnikrishnan R, et al. Risk factors for microvascular complications of diabetes among South Indian subjects with type 2 diabetes – the Chennai Urban Rural Epidemiology Study (CURES) Eye Study-5. Diabetes Technol Ther 2010;12:755–761.
   PubMed Web of Science ®Google Scholar
• Wong TY, Cheung N, Tay WT, et al. Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study. Ophthalmology 2008;115:1869–1875.
   PubMed Web of Science ®Google Scholar
• UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837–853.
   PubMed Web of Science ®Google Scholar
• Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995;28:103–117.
   PubMed Web of Science ®Google Scholar
• Shichiri M, Kishikawa H, Ohkubo Y, et al. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care 2000;23(Suppl. 2):B21–B29.
   PubMed Web of Science ®Google Scholar
• Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545–2559.
   PubMed Web of Science ®Google Scholar
• Ismail-Beigi F, Craven T, Banerji MA, et al. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet 2010;376:419–430.
   PubMed Web of Science ®Google Scholar
• Group AC, Patel A, MacMahon S, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560–2572.
   PubMed Web of Science ®Google Scholar
• Hemmingsen B, Lund SS, Gluud C, et al. Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials. BMJ 2011;343:d6898.
   PubMed Web of Science ®Google Scholar
• Duckworth W, Abraira C, Moritz T, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009;360:129–139.
   PubMed Web of Science ®Google Scholar
• Harris MI, Klein R, Cowie CC, et al. Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? A U.S. population study. Diabetes Care 1998;21:1230–1235.
   PubMed Web of Science ®Google Scholar
• Klein R, Moss SE, Klein BE, et al. The Wisconsin epidemiologic study of diabetic retinopathy. XI. The incidence of macular edema. Ophthalmology 1989;96:1501–1510.
   Google Scholar
• Klein R, Klein BE, Moss SE, et al. Is blood pressure a predictor of the incidence or progression of diabetic retinopathy? Arch Intern Med 1989;149:2427–2432.
   PubMed Web of Science ®Google Scholar
• Stratton IM, Kohner EM, Aldington SJ, et al. UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia 2001;44:156–163.
   PubMed Web of Science ®Google Scholar
• Tudor SM, Hamman RF, Baron A, et al. Incidence and progression of diabetic retinopathy in Hispanics and non-Hispanic whites with type 2 diabetes. San Luis Valley Diabetes Study, Colorado. Diabetes Care 1998;21:53–61.
   PubMed Web of Science ®Google Scholar
• van Leiden HA, Dekker JM, Moll AC, et al. Blood pressure, lipids, and obesity are associated with retinopathy: the Hoorn study. Diabetes Care 2002;25:1320–1325.
   PubMed Web of Science ®Google Scholar
• Matthews DR, Stratton IM, Aldington SJ, et al. Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69. Arch Ophthalmol 2004;122:1631–1640.
   PubMed Web of Science ®Google Scholar
• UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998;317:703–713.
   PubMedGoogle Scholar
• Estacio RO, Jeffers BW, Gifford N, et al. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Diabetes Care 2000;23(Suppl. 2):B54–B64.
   PubMed Web of Science ®Google Scholar
• Chaturvedi N, Sjolie AK, Stephenson JM, et al. Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus. Lancet 1998;351:28–31.
   Google Scholar
• Chaturvedi N, Porta M, Klein R, et al. Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials. Lancet 2008;372:1394–1402.
   PubMed Web of Science ®Google Scholar
• Sjolie AK, Klein R, Porta M, et al. Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial. Lancet 2008;372:1385–1393.
   PubMed Web of Science ®Google Scholar
• Mauer M, Zinman B, Gardiner R, et al. Renal and retinal effects of enalapril and losartan in type 1 diabetes. N Engl J Med 2009;361:40–51.
   PubMed Web of Science ®Google Scholar
• Beulens JW, Patel A, Vingerling JR, et al. Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial. Diabetologia 2009;52:2027–2036.
   PubMed Web of Science ®Google Scholar
• Lyons TJ, Jenkins AJ, Zheng D, et al. Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort. Invest Ophthalmol Vis Sci 2004;45:910–918.
   PubMed Web of Science ®Google Scholar
• Rema M, Srivastava BK, Anitha B, et al. Association of serum lipids with diabetic retinopathy in urban South Indians – the Chennai Urban Rural Epidemiology Study (CURES) Eye Study – 2. Diabet Med 2006;23:1029–1036.
   PubMed Web of Science ®Google Scholar
• Salinero-Fort MA, San Andres-Rebollo FJ, de Burgos-Lunar C, et al. Four-year incidence of diabetic retinopathy in a Spanish cohort: the MADIABETES study. PLoS One 2013;8:e76417.
   PubMedGoogle Scholar
• Wong TY, Klein R, Islam FM, et al. Diabetic retinopathy in a multi-ethnic cohort in the United States. Am J Ophthalmol 2006;141:446–455.
   PubMed Web of Science ®Google Scholar
• Morgan CL, Owens DR, Aubonnet P, et al. Primary prevention of diabetic retinopathy with fibrates: a retrospective, matched cohort study. BMJ Open 2013;3:e004025.
   Google Scholar
• Keech A, Simes RJ, Barter P, et al. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 2005;366:1849–1861.
   PubMed Web of Science ®Google Scholar
• Group AS, Group AES, Chew EY, et al. Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med 2010;363:233–244.
   PubMed Web of Science ®Google Scholar
• Staels B, Dallongeville J, Auwerx J, et al. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 1998;98:2088–2093.
   PubMed Web of Science ®Google Scholar
• Bordet R, Ouk T, Petrault O, et al. PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases. Biochem Soc Trans 2006;34:1341–1346.
   PubMed Web of Science ®Google Scholar
• Kim J, Ahn JH, Kim JH, et al. Fenofibrate regulates retinal endothelial cell survival through the AMPK signal transduction pathway. Exp Eye Res 2007;84:886–893.
   PubMed Web of Science ®Google Scholar
• Miranda S, Gonzalez-Rodriguez A, Garcia-Ramirez M, et al. Beneficial effects of fenofibrate in retinal pigment epithelium by the modulation of stress and survival signaling under diabetic conditions. J Cell Physiol 2012;227:2352–2362.
   PubMed Web of Science ®Google Scholar
• Villarroel M, Garcia-Ramirez M, Corraliza L, et al. Fenofibric acid prevents retinal pigment epithelium disruption induced by interleukin-1beta by suppressing AMP-activated protein kinase (AMPK) activation. Diabetologia 2011;54:1543–1553.
   PubMed Web of Science ®Google Scholar
• Wong TY, Simo R, Mitchell P. Fenofibrate – a potential systemic treatment for diabetic retinopathy? Am J Ophthalmol 2012;154:6–12.
   PubMed Web of Science ®Google Scholar
• Owens DR, Gibbins RL, Kohner E, et al. Diabetic retinopathy screening. Diabet Med 2000;17:493–494.
   PubMed Web of Science ®Google Scholar
• Backlund LB, Algvere PV, Rosenqvist U. New blindness in diabetes reduced by more than one-third in Stockholm County. Diabet Med 1997;14:732–740.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Executive summary: Standards of medical care in diabetes –2014. Diabetes Care 2014; 37(Suppl1.):S5–13.
   Google Scholar
• Harris NK, Talwar N, Gardner TW, et al. Predicting development of proliferative diabetic retinopathy. Diabetes Care 2013;36:1562–1568.
   PubMed Web of Science ®Google Scholar
• Fante RJ, Gardner TW, Sundstrom JM. Current and future management of diabetic retinopathy: a personalized evidence-based approach. Diabetes Manag (Lond) 2013;3:481–494.
   PubMedGoogle Scholar
• Harris NK, Talwar N, Gardner TW, et al. Predicting development of proliferative diabetic retinopathy. Diabetes Care 2013;36:1562–1568.
   PubMed Web of Science ®Google Scholar
• Gaede P, Vedel P, Larsen N, et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003;348:383–393.
   PubMed Web of Science ®Google Scholar
• Sandbaek A, Griffin SJ, Sharp SJ, et al. Effect of early multifactorial therapy compared with routine care on microvascular outcomes at 5 years in people with screen-detected diabetes: a randomized controlled trial: the ADDITION-Europe Study. Diabetes Care 2014;37:2015–2023.
   PubMed Web of Science ®Google Scholar
• Rema M, Premkumar S, Anitha B, et al. Prevalence of diabetic retinopathy in urban India: the Chennai Urban Rural Epidemiology Study (CURES) eye study, I. Invest Ophthalmol Vis Sci 2005;46:2328–2333.
   PubMed Web of Science ®Google Scholar
• Liu L, Wu X, Liu L et al. Prevalence of diabetic retinopathy in mainland China: a meta-analysis. PLoS One 2012;7:e45264.
   PubMed Web of Science ®Google Scholar
• Rani PK, Raman R, Chandrakantan A, et al. Risk factors for diabetic retinopathy in self-reported rural population with diabetes. J Postgrad Med 2009;55:92–96.
   PubMed Web of Science ®Google Scholar
• Wang FH, Liang YB, Zhang F, et al. Prevalence of diabetic retinopathy in rural China: the Handan Eye Study. Ophthalmology 2009;116:461–467.
   PubMed Web of Science ®Google Scholar
• World Health Organization, International Diabetes Federation. Diabetes action now. 2004. Accessed December 15, 2015 from: http://www. who int/diabetes/actionnow/booklet/en/
   Google Scholar
• World Health Organization. Prevention of blindness from diabetes mellitus. Report of a WHO Consultation in Geneva 2006.
   Google Scholar
• Tso MO. Changing scenery of eye care in China: from cataract to diabetic retinopathy. Arch Ophthalmol 2012;130:243–245.
   PubMedGoogle Scholar
• World Health Organization. Universal Eye Health: A global action plan 2014–2019. Prevention of blindness and visual impairment 2013.
   Google Scholar
• Khandekar R. Screening and public health strategies for diabetic retinopathy in the eastern Mediterranean region. Middle East Afr J Ophthalmol 2012;19:178–187.
   PubMedGoogle Scholar
• Manperumalsamy. Guidelines for the comprehensive management of diabetic retinopathy in India. Aravind Eye Care System, Madurai, India: A VISION 2020 The Right to Sight India Publication, 2008.
   Google Scholar
• von-Bischhoffshausen FB, Castro FM, Gomez-Bastar P. Planning diabetic retinopathy services – lessons from Latin America. Community Eye Health 2011;24:14–16.
   Google Scholar